Oral administration of an anti-FAP DNA vaccine markedly reduced new blood vessel formation, tumor growth, and metastasis in orthotopically injected breast carcinoma models (221), and the co-administration of doxorubicin significantly improved the drug’s intratumoral absorption and extended the survival of the treated mice (221). The gene discussed is FAP; the disease is neoplasm.